🚀 EU Warehouse 3 - tracking in 24 hours
Availability: 500 in stock
Couldn't load pickup availability
✅ By placing an order, you agree to the following conditions:
- EU Warehouse 1: tracking number is provided within 1 week after payment.
- EU Warehouse 2: tracking number is provided within 1 week after payment.
- EU Warehouse 3: tracking number is provided within 1 working day after payment.
Once shipped, delivery typically takes 1–2 weeks. Refunds are not offered for orders that are delayed in transit or processing.
📦 Delivery restrictions: We are currently unable to ship to Pack stations or P.O. boxes. Orders placed with such addresses will not be shipped and may face indefinite delay. Please use a valid residential or business address.
🌍 Shipping geography:
All products are shipped from Europe. Delivery within Europe takes approximately 4 - 10 days from the date of dispatch and passes customs smoothly.
Some of our products can be shipped worldwide (USA, UK, etc.). If you would like to place an order outside the European Union, please contact our manager first via Telegram or email at info@stero.me
📦 Tracking:
You will receive your tracking number after payment, according to the timeframes listed above per warehouse.
🚚 Important: When ordering items from different warehouses, an additional shipping charge applies.




Letrozole is a medication widely used for treating certain types of breast cancer in women. Particularly, it is prescribed for postmenopausal females with hormone receptor-positive breast cancer. These characteristics make Letrozole a crucial component in the management of hormone-sensitive malignancies.
It works by inhibiting an enzyme crucial for estrogen production, effectively reducing estrogen levels in the body. This is important because many breast cancers grow in response to estrogen. By blocking estrogen synthesis, Letrozole helps slow down or stop the growth of tumors.
Letrozole is typically well-tolerated; however, some patients might experience side effects. These can include hot flashes, joint pain, and fatigue. It's important to discuss potential risks and benefits with your healthcare provider. Depending on individual health profiles and treatment goals, they can guide the best approach to using Letrozole effectively.
Furthermore, Letrozole may also be used off-label for conditions like ovulatory dysfunction and infertility in women seeking to conceive. This dual application demonstrates its versatility within endocrine therapies.
Regular monitoring and follow-ups are essential while on Letrozole to assess its effectiveness and manage any side effects. Patients should also report any unusual symptoms, such as severe joint pain or swelling. Proper medical guidance will ensure that the treatment aligns with the specific needs of the patient.
In conclusion, Letrozole represents a significant advancement in the pharmacological management of hormone-sensitive breast cancer, offering many women a chance for improved outcomes and quality of life. Continuing research and clinical trials further expand the understanding of its efficacy and potential applications.